Home > products > custom-nanocomposites
> fluorescent-labeled-nanocomposites
> fitc-targeting-peptide-asp8-modified-liposomes-dha-ceramide
FITC+targeting peptide Asp8 modified liposomes@DHA Ceramide
FITC+targeting peptide Asp8 modified liposomes loaded with DHA Ceramide
Product description
FITC+targeting peptide Asp8 modified liposomes@DHA Ceramide/FITC and peptide Asp8 modified liposome loaded DHA Ceramide is an intelligent nano drug carrier system that integrates visual tracking, bone targeted delivery, and anti-tumor functions, suitable for targeted therapy and mechanism research of bone related diseases such as bone tumors and bone metastatic cancer.
| Appearance | Freeze-dried powder |
|---|---|
| Size | 100-200nm |
| Solubility | N/A |
| Drug loading | 6.8% (DHA Ceramide) |
| Encapsulation efficiency | 97.1%(DHA Ceramide) |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 1-3 weeks |
| Stability | 6 months |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of FITC+targeting peptide Asp8 modified liposomes@DHA Ceramide
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


